Bristol-Myers Squibb (BMY) Stock Research, Analysis & News

Quick Analysis on Bristol-Myers Squibb (BMY) Stock as of December 12, 2017

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about Bristol-Myers Squibb (BMY) Stock below)

Bristol-Myers Squibb (BMY) Stock Profile Summary

Bristol-Myers Squibb Company, a global biopharmaceutical company, engages in discovering, developing, and delivering medicines that help patients prevail over serious diseases. The company focuses on areas of serious unmet medical need, such as affective (psychiatric) disorders, Alzheimers/dementia, cardiovascular (primarily atherosclerosis/thrombosis), diabetes, hepatitis, HIV/AIDS, obesity, oncology, rheumatoid arthritis and related diseases, and solid organ transplant. Its products include PLAVIX for protection against fatal or non-fatal heart attack or stroke, and AVAPRO/AVALIDE for the treatment of hypertension and diabetic nephropathy; REYATAZ and SUSTIVA Franchise for the treatment of HIV, and BARACLUDE for the treatment of chronic hepatitis B infection; ERBITUX, SPRYCEL, and IXEMPRA for treating oncology related diseases; ABILIFY, a medicine for the treatment of mental illness; ORENCIA, a medicine for rheumatoid arthritis; and ONGLYZA for the treatment of type 2 diabetes. The company also has a pipeline with compounds in phase III clinical trials, including apixaban, belatacept, brivanib, dapagliflozin, ipilimumab, necitumumab, and XL-184. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, and pharmacies. Bristol-Myers Squibb Company has various alliances and collaborations with sanofi-aventis; Otsuka Pharmaceutical Co., Ltd.; Eli Lilly and Company; Gilead Sciences, Inc.; AstraZeneca PLC; Pfizer Inc.; Exelixis, Inc.; ZymoGenetics, Inc.; Alder Biopharmaceuticals, Inc.; and Simcere Pharmaceutical Group. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.

Bristol-Myers Squibb (BMY) Stock Key Statistics Research and Analysis as of December 12, 2017

Bristol-Myers Squibb (BMY) Stock Competitor Research and Analysis

AstraZeneca PLC (AZN)Merck & Co. Inc. (MRK)
Pfizer Inc. (PFE)Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)Life Technologies Corporation (LIFE)
Teva Pharmaceutical Industries Limited (TEVA)Watson Pharmaceuticals Inc. (WPI)
King Pharmaceuticals Inc. (KG)Mylan, Inc. (MYL)
Johnson & Johnson (JNJ)GlaxoSmithKline plc (GSK)
Sanofi-Aventis (SNY)Novartis AG (NVS)

Mutual Funds with Bristol-Myers Squibb (BMY) Stock in its top 10 holdings

FundCategoryBMY Holding Percentage
American Century Select CLarge Growth3.11%
Alger Health Sciences AHealth5.18%
Prudential Jennison Equity Income CLarge Blend3.73%
Alger Health Sciences BHealth5.18%
Amana Income InvestorLarge Blend3.66%
American Century Select RLarge Growth3.11%
William Blair Growth ILarge Growth3.35%

ETFs with Bristol-Myers Squibb (BMY) Stock in its top 10 holdings

Stock Research on Bristol-Myers Squibb (BMY)

Latest Market News on Bristol-Myers Squibb (BMY)


Click here to find the latest news on Bristol-Myers Squibb (BMY)

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

AstraZeneca PLC (AZN)
Merck & Co. Inc. (MRK)
Pfizer Inc. (PFE)
Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)
Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)
Life Technologies Corporation (LIFE)
Teva Pharmaceutical Industries Limited (TEVA)
Watson Pharmaceuticals Inc. (WPI)
King Pharmaceuticals Inc. (KG)
Mylan, Inc. (MYL)
Johnson & Johnson (JNJ)
GlaxoSmithKline plc (GSK)
Sanofi-Aventis (SNY)
Novartis AG (NVS)